Challenge and cat | Viremia status at the following time (wk p.i.)^{a}: | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|

4 | 6 | 8 | 10 | 12 | 14 | 18 | 22 | 28 | 32 | 36 | 43 | 54 | 56 | 58 | 66 | 69 | >73 | |

pF6A | ||||||||||||||||||

5051 | + A | + A | + A | + A | + A/B | + A | + A | + A/B | + A/B | + A/B | + A/B | + A/B | + | D-TLSA | ||||

5035 | + A | + A | + A | + A | + A | + A/B | + A/B | + A/B | + A/B | + A/B | + A/B | + | + | + | + | + | D-TLSA | |

5036 | + | + A | + A | + A | + A | + A | + A | + A/B | + A/B | + A/B | + | + A/B | + | + | + | D-TLSA | ||

5037 | − | + A | + A | + | + | + A | + A | + A | + A | + A | + | + A | + | + | + | + | + | Alive |

pFRA | ||||||||||||||||||

5039 | + | + A | + | + A | + | + A/B | + A/B | + A/B | + A/B | + A/B | + | D-TLSA | ||||||

5040 | − | + A | + | + A | + | + A | + A/C | + A/C | + A/C | + A/C | + A/C | + A/C | D-AN | |||||

5041 | + | + A | + | + A | + | + A | + A | + A | + A/B | + A/B | + A | + A | + | + | D-BCL |

↵a Viremia status is depicted as − (negative) or + (positive); subgroup determinations are based on interference assay, and the results are shown as A, A/B, or A/C where such tests were performed. Abbreviations: D, died; TLSA, thymic lymphosarcoma; AN, anemia; BCL, B-cell lymphoma.